Novo Nordisk A/S

Novo Nordisk is a focused global healthcare company with 89 years of innovation and leadership in diabetes care. With the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems, Novo Nordisk is a world leader in diabetes care. 

Novo Nordisk A/S completed participation in PCDIAB August 2014.